NCT03916809Recruiting
EMST in Patients Undergoing CRT for HNCA
Impact of Expiratory Muscle Strength Training (EMST) on Swallowing Function in Persons Undergoing Radiotherapy With or Without Chemotherapy (CRT) for Cancers of the Head and Neck (HNCA)
Source: ClinicalTrials.gov · Last updated 4 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is a randomized trial examining the impact of expiratory muscle strength training (EMST) on maintenance of safe and efficient oropharyngeal swallow function in persons with cancer of the head and neck (HNCA) undergoing treatment with radiation therapy or chemoradiotherapy (RT/CRT).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 11 Apr 2019
- Start date
- 12 Jul 2017
- Primary completion date
- 1 Aug 2025
- Lead sponsor
- University of Wisconsin, Milwaukee
- Diseases
- Head and neck cancer
- NCT number
- NCT03916809
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 12 Jul 2017 to the primary completion date, 1 Aug 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Primary surgery to the head and neck (neck dissection is permitted);
- Prior history of head and neck radiotherapy
Other illness
- Primary cancers of the nasopharynx, paranasal sinuses, salivary glands and skin.
- Progressive neurologic condition affecting muscle strength (e.g. amyotrophic lateral sclerosis (ALS), Parkinson's disease)
- Dysphagia not related to HNCA (e.g. unresolved swallowing difficulty post-stroke or post--traumatic brain injury (TBI))
Other
- Unknown primary tumor;
Who the study is looking for
- New diagnosis of cancer in the oral cavity, oropharynx, hypopharynx, or larynx;
- Planned treatment with primary radiotherapy with or without chemotherapy;
- Age 18 or older and able to provide consent;
- Ability to use the EMST150 device (hold in mouth and maintain lip seal)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Wisconsin Milwaukee Coordinator of this site? Confirm its status | Milwaukee | United States | Active, not recruiting |
| Froedtert Hospital Coordinator of this site? Confirm its status | Milwaukee | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.